Literature DB >> 14668785

A conceptual paradox of MIBG uptake in heart failure: retention with incontinence!

Jagat Narula, Kunal Sarkar.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14668785     DOI: 10.1016/j.nuclcard.2003.09.006

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN: 1071-3581            Impact factor:   5.952


× No keyword cloud information.
  33 in total

1.  Adrenergic-receptor polymorphisms and heart failure.

Authors:  Roger J Hajjar; Calum A MacRae
Journal:  N Engl J Med       Date:  2002-10-10       Impact factor: 91.245

2.  Cardiac sympathetic nerve function in congestive heart failure.

Authors:  G Eisenhofer; P Friberg; B Rundqvist; A A Quyyumi; G Lambert; D M Kaye; I J Kopin; D S Goldstein; M D Esler
Journal:  Circulation       Date:  1996-05-01       Impact factor: 29.690

Review 3.  Management of arrhythmias in heart failure.

Authors:  Kristin E Ellison; William G Stevenson; Mihael O Sweeney; Laurence M Epstein; William H Maisel
Journal:  Congest Heart Fail       Date:  2003 Mar-Apr

4.  Synergistic polymorphisms of beta1- and alpha2C-adrenergic receptors and the risk of congestive heart failure.

Authors:  Kersten M Small; Lynne E Wagoner; Albert M Levin; Sharon L R Kardia; Stephen B Liggett
Journal:  N Engl J Med       Date:  2002-10-10       Impact factor: 91.245

5.  Effect of cardiac sympathetic nervous activity on mode of death in congestive heart failure.

Authors:  H P Brunner-La Rocca; M D Esler; G L Jennings; D M Kaye
Journal:  Eur Heart J       Date:  2001-07       Impact factor: 29.983

6.  Regulation of receptor fate by ubiquitination of activated beta 2-adrenergic receptor and beta-arrestin.

Authors:  S K Shenoy; P H McDonald; T A Kohout; R J Lefkowitz
Journal:  Science       Date:  2001-10-04       Impact factor: 47.728

Review 7.  Prevention and management of chronic heart failure with electrical therapy.

Authors:  Erica D Engelstein
Journal:  Am J Cardiol       Date:  2003-05-08       Impact factor: 2.778

8.  Abnormal I-123 metaiodobenzylguanidine myocardial washout and distribution may reflect myocardial adrenergic derangement in patients with congestive cardiomyopathy.

Authors:  E B Henderson; J K Kahn; J R Corbett; D E Jansen; J J Pippin; P Kulkarni; V Ugolini; M S Akers; C Hansen; L M Buja
Journal:  Circulation       Date:  1988-11       Impact factor: 29.690

9.  Prognostic value of repeated 123I-metaiodobenzylguanidine imaging in patients with dilated cardiomyopathy with congestive heart failure before and after optimized treatments--comparison with neurohumoral factors.

Authors:  Toshiki Matsui; Takayoshi Tsutamoto; Keiko Maeda; Junya Kusukawa; Masashiko Kinoshita
Journal:  Circ J       Date:  2002-06       Impact factor: 2.993

10.  Association between tyrosine hydroxylase polymorphisms and left ventricular structure in young normotensive men.

Authors:  Ales Linhart; Antonín Jindra; Lubor Golán; Marie Jáchymová; Kamil Sedlácek; Jan Peleska; Vera Umnerová; Jan Bultas; Karel Horký; Michael Aschermann
Journal:  Br J Biomed Sci       Date:  2002       Impact factor: 3.829

View more
  3 in total

Review 1.  Cardiovascular molecular imaging: focus on clinical translation.

Authors:  Ian Y Chen; Joseph C Wu
Journal:  Circulation       Date:  2011-02-01       Impact factor: 29.690

2.  Extension of myocardial necrosis differently affects MIBG retention in heart failure caused by ischaemic heart disease or by dilated cardiomyopathy.

Authors:  Cecilia Marini; Assuero Giorgetti; Alessia Gimelli; Annette Kusch; Nadia Sereni; Antonio L'abbate; Paolo Marzullo; Gianmario Sambuceti
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-03-04       Impact factor: 9.236

3.  Altered sympathetic nervous system signaling in the diabetic heart: emerging targets for molecular imaging.

Authors:  James T Thackeray; Rob S Beanlands; Jean N Dasilva
Journal:  Am J Nucl Med Mol Imaging       Date:  2012-07-20
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.